Literature DB >> 24167694

Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

W Victor R Vieweg1, Mehrul Hasnain, Robert H Howland, Thomas Clausen, Jayanthi N Koneru, Christopher Kogut, Ericka L Breden Crouse, Jules C Hancox, Antony Fernandez, Ananda K Pandurangi.   

Abstract

We reviewed the literature and found 31 adult cases and 1 newborn case of methadone-associated QTc interval prolongation and/or torsade de pointes (TdP). Parametric statistics may not be useful in studying this issue because methadone-associated TdP is a very rare event and, hence, "an extreme outlier" consistent with scalable randomness. We may have to rely upon narrative medicine in the form of case reports with all its limitations and hazards to provide our best understanding. We report risk factors for methadone-associated QTc interval prolongation and TdP based on review of published case reports. We believe both drug manufacturers and the FDA would better serve our patients and inform clinicians if they more readily reported drug-induced outliers such as methadone-associated TdP using a case report format.

Entities:  

Keywords:  Drug-induced QTc interval prolongation; methadone; risk factors; torsade de pointes

Year:  2013        PMID: 24167694      PMCID: PMC3805428          DOI: 10.1177/2045125312469982

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  75 in total

Review 1.  Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk.

Authors:  Gary A Gintant
Journal:  Pharmacol Ther       Date:  2008-06-18       Impact factor: 12.310

Review 2.  Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; John M Hettema; Christopher Kogut; Mark A Wood; Ananda K Pandurangi
Journal:  Am J Med       Date:  2012-06-27       Impact factor: 4.965

3.  Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.

Authors:  Kuan-Cheng Chang; Chieh-Liang Huang; Hsin-Yueh Liang; Shih-Sheng Chang; Yu-Chen Wang; Wen-Miin Liang; Hsien-Yuan Lane; Chu-Huang Chen; Shoei K Stephen Huang
Journal:  J Cardiovasc Electrophysiol       Date:  2011-12-02

4.  Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.

Authors:  Alexander N Katchman; Kelly A McGroary; Michael J Kilborn; Craig A Kornick; Paolo L Manfredi; Raymond L Woosley; Steven N Ebert
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

5.  Ventricular arrhythmias in patients treated with methadone for opioid dependence.

Authors:  Sam Hanon; Randy M Seewald; Felix Yang; Paul Schweitzer; Jonathan Rosman
Journal:  J Interv Card Electrophysiol       Date:  2010-02-23       Impact factor: 1.900

6.  Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.

Authors:  Katinka Anchersen; Viggo Hansteen; Michael Gossop; Thomas Clausen; Helge Waal
Journal:  Drug Alcohol Depend       Date:  2010-08-10       Impact factor: 4.492

Review 7.  Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

Authors:  R L Deamer; D R Wilson; D S Clark; J G Prichard
Journal:  J Addict Dis       Date:  2001

8.  Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy.

Authors:  Md Haris Robson NoorZurani; Balasingam Vicknasingam; Suresh Narayanan
Journal:  Drug Alcohol Rev       Date:  2009-11

9.  Methadone-induced torsade de pointes in a patient with normal baseline QT interval.

Authors:  Ammar Almehmi; Amer M Malas; Mohammed Yousufuddin; J Gregory Rosencrance
Journal:  W V Med J       Date:  2004 Jul-Aug

10.  Chronic methadone therapy complicated by torsades de pointes: a case report.

Authors:  Laura Pimentel; Douglas Mayo
Journal:  J Emerg Med       Date:  2007-11-26       Impact factor: 1.484

View more
  14 in total

1.  Need for a more developmental perspective: QTc prolongation under psychotropic medication.

Authors:  Veit Roessner; Nicole Wolff; Stefan Ehrlich; Robert Waltereit
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-08       Impact factor: 4.785

2.  Cardiovascular disease among people with drug use disorders.

Authors:  Birgitte Thylstrup; Thomas Clausen; Morten Hesse
Journal:  Int J Public Health       Date:  2015-06-24       Impact factor: 3.380

Review 3.  Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Authors:  Mehrul Hasnain; W Victor R Vieweg; Robert H Howland; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Jules C Hancox; Geneviève C Digby; Adrian Baranchuk; Anand Deshmukh; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2014-06

Review 4.  Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Jules C Hancox; Adrian Baranchuk; Geneviève C Digby; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Anand Deshmukh; Ananda K Pandurangi
Journal:  Psychopharmacology (Berl)       Date:  2013-06-30       Impact factor: 4.530

5.  Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.

Authors:  W Victor R Vieweg; Jules C Hancox; Mehrul Hasnain; Jayanthi N Koneru; Michael Gysel; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2013-08

6.  Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.

Authors:  Jules C Hancox; Mehrul Hasnain; W Victor R Vieweg; Ericka L Breden Crouse; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2013-10

7.  QTc Prolongation in Veterans With Heroin Dependence on Methadone Maintenance Treatment.

Authors:  Sameer Hassamal; Antony Fernandez; Hossein Moradi Rekabdarkolaee; Ananda Pandurangi
Journal:  Int J High Risk Behav Addict       Date:  2015-06-20

Review 8.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

Review 9.  Practical Pharmacology of Methadone: A Long-acting Opioid.

Authors:  M M Sunilkumar; Kashelle Lockman
Journal:  Indian J Palliat Care       Date:  2018-01

10.  Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity.

Authors:  Jules C Hancox; Mehrul Hasnain; W Victor R Vieweg; Michael Gysel; Michelle Methot; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.